Recruiting
Phase 2

Mosunetuzumab

Sponsor:

University of Washington

Code:

NCT06442475

Conditions

Ann Arbor Stage II Follicular Lymphoma

Ann Arbor Stage II Marginal Zone Lymphoma

Ann Arbor Stage III Follicular Lymphoma

Ann Arbor Stage III Marginal Zone Lymphoma

Ann Arbor Stage IV Follicular Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Computed Tomography

Magnetic Resonance Imaging

Mosunetuzumab

Positron Emission Tomography

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-23. This information was provided to ClinicalTrials.gov by University of Washington on 2025-09-04.